McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Technology analyst Beth Kindig believes Nvidia will be worth $10 trillion by 2030. One of Wall Street's most accurate ...

The global healthcare IT market size was valued at USD 280 billion in 2024 and is expected to reach around USD 1,404.55 ...

Activists display a 10 metre long climate invoice directed at developed countries at a protest during the United Nations Climate Change Conference (COP29), in Baku, Azerbaijan November 14, 2024 ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

Former Democratic congresswoman Tulsi Gabbard has been appointed as the director of national intelligence by US President-elect Donald Trump. Gabbard, who switched to the Republican Party, is a ...

Mom of 3 was brutally tortured before being set ablaze in Manipur: Autopsy A horrifying incident in Manipur's Jiribam district has left the community reeling after a 31-year-old mother of three ...

Jury deliberations began on Friday, Nov. 8, and concluded Tuesday afternoon. Following a six-week trial, the jury decided drug distributors McKesson and AmerisourceBergen would split the $266 million ...